Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin

Investigational Site Number 156001, Beijing

Investigational Site Number 156033, Beijing

Investigational Site Number 156006, Beijing

Investigational Site Number 156005, Beijing

Investigational Site Number 156004, Beijing

Investigational Site Number 156002, Beijing

Investigational Site Number 156032, Shenyang

Investigational Site Number 156034, Dalian

Investigational Site Number 156016, Changchun

Investigational Site Number 156036, Siping

Investigational Site Number 156017, Harbin

Investigational Site Number 643003, Saint Petersburg

Investigational Site Number 643004, Saint Petersburg

Investigational Site Number 643005, Saint Petersburg

Investigational Site Number 156028, Shanghai

Investigational Site Number 156007, Shanghai

Investigational Site Number 156019, Nanjing

Investigational Site Number 156020, Nanjing

Investigational Site Number 156010, Suzhou

Investigational Site Number 156026, Jinan

Investigational Site Number 156029, Jinan

Investigational Site Number 156018, Qingdao

Investigational Site Number 156008, Tianjin

Investigational Site Number 156035, Fuzhou

Investigational Site Number 356019, Ahmedabad

Investigational Site Number 156025, Changsha

Investigational Site Number 356008, Pune

Investigational Site Number 156027, Wuhan

Investigational Site Number 356015, Nagpur

Investigational Site Number 643006, Samara

Investigational Site Number 356021, Secunderabad

Investigational Site Number 356002, Hyderabad

Investigational Site Number 356024, Hyderabad

Investigational Site Number 156021, Guangzhou

Investigational Site Number 356023, Visakhapatnam

Investigational Site Number 356026, Bangalore

Investigational Site Number 156023, Haikou

Investigational Site Number 643007, Kirov

Investigational Site Number 156014, Chengdu

Investigational Site Number 156013, Chengdu

Investigational Site Number 156011, Xi'an

Investigational Site Number 156012, Xi'an

Investigational Site Number 356017, Bhubaneswar

Investigational Site Number 156009, Shijiazhuang

Investigational Site Number 356018, Aligarh

Investigational Site Number 410003, Daegu

Investigational Site Number 410007, Goyang

Investigational Site Number 410006, Seoul

Investigational Site Number 410001, Seoul

Investigational Site Number 410005, Seoul

Investigational Site Number 410002, Wŏnju